Let's Examine "Unofficial Spokesman" DR Jack West's Changed Opinion on BLP25
My comments in [ ]
"H. Jack West, MD
I'm impressed by that 10.2 mo improvement in median OS in subset of 800 pts who received BLP-25 after concurrent chemo/RT #ASCO13
Reply Retweet Favorite More
1 [So apparently he changed his usual doomed opinion towards BLP25, and he was impressed]
8:17 AM - 4 Jun 13
Colfax @ColfaxCapital 58m
@JackWestMD But they cannot file w regulators based on that data; so, more trials... PD-1 will make this irrelevant [this guys probably is a short on onty but long PD-1 drug maker and he is anxious about the potential approval of BLP-25. He hope he is the guy sitting in FDA]
H. Jack West, MD @JackWestMD 52m
@ColfaxCapital agree on all counts. Scientific Qs independent of practical realities." [What a pathetic reply which even has nothing to reflect he is a doctor]
When WS is awaken, and realized it has not been in the position of significant shareholders, it manipulates. The same thing happens in MCP, BBRY until WS crooks have taken their positions. The share price could be at any levels.
He admitted "excited on the START subgroup" results, and thought a redux trial was needed for approval; he still plays a tricky card not appropriate for a profession called medical care docs, and specifically in his case a lung cancer oncologist. How can any patients would trust him is out of my comprehension!
How this "influential" onco doc saying thing like this is disturbing to patients and their families and definitely out of comprehension!
How can he be trusted by his patients. He should be sent back to medical school to redo his courses and training, or change his career to being "a Wall Street stock analyst," or "a museum archaeologist" specializing in historical cancer treatment.
America does not lack doctors, but good doctors or doctors with hearts!
Absolutely. Unless Both Gentlemen have loved ones who have Stage III lung cancer, then ask them again what are their opinions about approval of BLP25 for treating Stage III lung cancer patients after concurrent chemo/RT.